3.3
204 ื‘ื™ืงื•ืจื•ืช
+50Kโ€
ื”ื•ืจื“ื•ืช
ืกื™ื•ื•ื’ ืชื•ื›ืŸ
ื›ื•ืœื
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš

ืžื™ื“ืข ืขืœ ืืคืœื™ืงืฆื™ื” ื–ื•

ืžื•ื˜ื‘ ืž-VITAL Health Plan, ื›ืขืช ืชื•ื›ืœ ืœืงื‘ืœ ืžื™ื“ืข ืขืœ ื”ืฉื™ืจื•ืชื™ื ื•ื”ื–ื›ืื•ืช ืฉืœืš ื“ืจืš ืืคืœื™ืงืฆื™ื™ืช VITAL Mobile.
ืขื™ืฆื•ื‘ ืื™ื ื˜ื•ืื™ื˜ื™ื‘ื™ ื•ืงืœ ืœื ื™ื•ื•ื˜ ื”ืžืกืคืง ื–ืจื™ื–ื•ืช ื‘ืฆื•ืจื” ื”ื ื•ื—ื” ื‘ื™ื•ืชืจ ืฉื™ืฉ, ื–ืžื™ืŸ ื‘ืกืคืจื“ื™ืช ื•ื‘ืื ื’ืœื™ืช.

ื”ื•ืจื“ ืืช ืืคืœื™ืงืฆื™ื™ืช VITAL Mobile, ืจืฉื•ื ืืช ื—ืฉื‘ื•ื ืš ื•ืชื•ื›ืœ:
* ื’ื™ืฉื” ื ื•ื—ื” ื•ื‘ื˜ื•ื—ื” ื‘ืืžืฆืขื•ืช ื–ื™ื”ื•ื™ ืคื ื™ื ื•ื˜ื‘ื™ืขื•ืช ืืฆื‘ืข
* ื’ืฉ ืœื›ืจื˜ื™ืก ื”ื•ื•ื™ืจื˜ื•ืืœื™ ืฉืœ VITAL Plan ืžื›ืœ ืžืงื•ื
* ื“ืข ืืช ืกื˜ื˜ื•ืก ื”ื–ื›ืื•ืช ืฉืœืš, ืชืืจื™ืš ื›ื ื™ืกืชืš ืœืชื•ืงืฃ, ื ื™ื”ื•ืœ ืืจื’ื•ืŸ ื˜ื™ืคื•ืœ (MCO), ืงื‘ื•ืฆื” ืจืคื•ืื™ืช ืจืืฉื•ื ื™ืช (PMG) ื•ืจื•ืคื ืจืืฉื•ื ื™ (PCP)
* ืงื‘ืข ืคื’ื™ืฉื” ื•ื™ืจื˜ื•ืืœื™ืช ืขื ื™ื•ืขืฅ ื”ื”ืจืฉืžื”
* ืงื‘ืœ ื”ืชืจืื•ืช ื•ื”ื•ื“ืขื•ืช ืื•ื˜ื•ืžื˜ื™ื•ืช ืขืœ ืฉื™ื ื•ื™ื™ื ื‘ื”ืจืฉืžื”, ืชื–ื›ื•ืจื•ืช ืœืื™ืฉื•ืจ ืžื—ื“ืฉ, ืื™ืจื•ืขื™ื, ืชืงื•ืคืช ื”ืจืฉืžื” ืคืชื•ื—ื”
* ืฉืœื™ื—ืช ื”ื•ื“ืขื•ืช ืœื™ื•ืขืฆืช ื”ื”ืจืฉืžื” ืœืฉืืœื•ืช, ืจื•ืคืื™ื, ืชื•ืจื™ื
* ืืชืจ ืืช ืžืฉืจื“ื™ Medicaid ื‘ืงืจื‘ืช ืžืงื•ื ื•ืืช ื”ืžืกืœื•ืœื™ื ื”ืžื”ื™ืจื™ื ื‘ื™ื•ืชืจ
* ืฉืืœื•ืช ื ืคื•ืฆื•ืช

ืกืคืงื™ ืชื›ื ื™ืช VITAL ื•ืžื•ื˜ื‘ื™ื ืคื•ื˜ื ืฆื™ืืœื™ื™ื ื™ื•ื›ืœื• ื’ื ืœืงื‘ืœ ืืช ื”ืฉื™ืจื•ืชื™ื ื”ื‘ืื™ื:
* ืืชืจ ืืช ืžืฉืจื“ื™ Medicaid ื•ืžืกืœื•ืœื™ื ื‘ืงืจื‘ืช ืžืงื•ื
* ืฉืืœื•ืช ื ืคื•ืฆื•ืช (ืฉืืœื•ืช ื ืคื•ืฆื•ืช)
* MPI ื—ื™ืคื•ืฉ ืฉื™ื•ืš ืžื‘ื˜ื—
ืขื“ื›ื•ืŸ ืื—ืจื•ืŸ ื‘ืชืืจื™ืš
26 ื‘ืžืจืฅ 2024

ืื‘ื˜ื—ืช ื ืชื•ื ื™ื

ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ื”ื‘ื˜ื™ื—ื•ืช ืฆืจื™ืš ืงื•ื“ื ื›ืœ ืœื”ื‘ื™ืŸ ืื™ืš ื”ืžืคืชื—ื™ื ืื•ืกืคื™ื ื•ืžืฉืชืคื™ื ืืช ื”ื ืชื•ื ื™ื ืฉืœืš. ื ื•ื”ืœื™ ืคืจื˜ื™ื•ืช ื”ื ืชื•ื ื™ื ื•ืื‘ื˜ื—ืช ื”ื ืชื•ื ื™ื ืขืฉื•ื™ื™ื ืœื”ืฉืชื ื•ืช ื‘ื”ืชืื ืœืฉื™ืžื•ืฉ, ืœืื–ื•ืจ ื•ืœื’ื™ืœ ื”ืžืฉืชืžืฉ. ื”ืžืคืชื— ืกื™ืคืง ืืช ื”ืžื™ื“ืข ื”ื–ื” ื•ื”ื•ื ืขืฉื•ื™ ืœืขื“ื›ืŸ ืื•ืชื• ืžื“ื™ ืคืขื.

ื“ื™ืจื•ื’ื™ื ื•ื‘ื™ืงื•ืจื•ืช

3.2
194 ื‘ื™ืงื•ืจื•ืช

ืžื” ื—ื“ืฉ

This new release includes new document categories when beneficiaries send evidence for their Recertification Application and validates the process when sendingย theย documents.